Uptake of Low-Dose Tamoxifen for Risk Reduction in Mayo Clinic 
Christine L. Klassen, MD

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Review the data for use of Tamoxifen for breast cancer risk reduction
• Describe the uptake of low-dose Tamoxifen" study completed at Mayo Clinic
• Assess the improvement in uptake for low-dose Tamoxifen compared to standard dose tamoxifen
• Propose future studies for use of low-dose Tamoxifen

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. Attendance must be manually recorded in MedHub. Contact MSCGME support staff for assistance.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.